Clinical trials
Skin Necrosis clinical trials
Below are recruiting skin necrosis clinical trials, each written for real people, not researchers. We’re tracking 2 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05162677Recruiting
Study skin thickness and tissue after preventive breast removal
This study looks at what happens to the skin and remaining breast tissue after a preventive (non-cancer) mastectomy. It uses imaging and exams to understand why some patients may have skin healing problems.
UmeåAges 18–74 - NCT05910931Recruiting
Fluorescent dye camera test to spot breast surgery complications
This study tests whether a special dye and camera during breast surgery can help doctors find complications early. It may help improve safety after breast-conserving surgery or mastectomy with implant reconstruction.
A CoruñaAges 18–100
Hear when a new Skin Necrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for skin necrosis?
- Yes. Clin2 currently lists 2 recruiting skin necrosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a skin necrosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a skin necrosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.